Ambiq Q2 sales up 90% to $33.9 million; Q3 outlook $36.0 million to $37.0 million
Ambiq reported second-quarter 2026 net sales of $33.9 million, up 89.7% from a year earlier, and its GAAP net loss narrowed to $7.1 million from $8.5 million. The company expects third-quarter net sales of $36.0 million to $37.0 million, with growth partially constrained by industry-wide supply availability. A June public offering raised approximately $168 million in net proceeds, adding to the company's capital base.
Key points
- Q2 2026 net sales of $33.9 million, up 89.7% from $17.9 million in Q2 2025
- GAAP net loss of $7.1 million, compared with $8.5 million a year earlier; GAAP gross margin of 45.0%
- Q3 2026 guidance: net sales of $36.0 million to $37.0 million; non-GAAP net loss per share of ($0.20) to ($0.12)
- Completed an upsized public offering in June 2026, raising approximately $168 million in net proceeds
The filing
Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 11, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.